News

dLocal stands out over Priority with faster payment growth, a broader emerging-market network and stronger cash resources despite margin risks.

Amgen heads into Q2 earnings with a history of beats as investors watch key drug sales trends and seek updates on its MariTide obesity candidate.

AbbVie tops Q2 earnings and revenue estimates on strong immunology drug sales, but a lower 2026 EPS outlook tied to the Apogee deal weighs on shares.

(Bloomberg) -- Short sellers have piled into SpaceX at a rapid pace ahead of two major milestones next week: the company’s first earnings report as a public company and the release of hundreds of millions of locked-up shares.Most Read from BloombergSingapore's Gated Island for the Rich Is Marred by Decayed HomesAnthropic AI Models Hacked Three Organizations During TestsMicrosoft’s $450 Billion Jump Is Biggest in Stock Market HistoryChip Stocks Post Biggest Advance Since April 2025: Markets WrapM

NXP Semiconductors is in talks to buy chip ‌designer Ambarella, the Financial ‌Times reported on Friday, citing people familiar with the ​matter. Shares of Ambarella, with a market capitalization of $3.25 billion, jumped nearly 17%, while NXP fell over 3% ‌following the ⁠report. Here are a few details: • A potential deal could ⁠bolster NXP's capabilities in software-defined vehicles, radar and electrification, as Ambarella ​develops low-power ​AI chips ​and software for ‌edge devices such as cameras, vehicles and robotics.

Garmin may look expensive, but there is something many investors are missing.

Amazon stock is racing toward its best trading day in more than a decade following its Q2 results. A strong performance from its cloud-computing division is helping ease fears that the tech giant could lose ground to rival offerings from Microsoft and Google parent Alphabet. "Amazon Web Services finally saw the long-awaited growth inflection, shooting to the top of the cloud wars as AI quarter-to-quarter revenue mimics Anthropic's meteoric rise," Bernstein analyst Mark Shmulik wrote to clients Friday following Amazon's report.

Alaska Air is betting on premium travel, loyalty, long-haul growth and fleet upgrades to improve revenue quality amid execution demands.

Patient NuScale shareholders could be richly rewarded as it moves SMR technology toward deployment.

Following changes to price targets from multiple analysts, Datadog, Inc. (NASDAQ:DDOG) climbed 7.7%. On July 28, 2026, analysts at Morgan Stanley, BTIG, and Citi raised their price targets on Datadog to $300, $289, and $300, respectively, reflecting changes between 11%-33%, while maintaining bullish ratings. Price targets from analysts usually come after a stock’s fundamentals have […]

The major indexes fell and AI stocks dived through midweek, partly on soaring oil and yields, but Microsoft and Amazon provided support.

IDCC beat Q2 estimates, raised 2026 revenue guidance and posted record recurring revenue, but investors still face valuation and licensing-related risks.

Aehr Test Systems (AEHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Although the EV maker continues to reduce its losses, it has never turned a profit and executives expect sustained headwinds due to external cost pressures.

IHE's pharma-focused portfolio delivered higher returns over the past year, while XLV offers a broader healthcare focus with a much lower expense ratio.

Social media stocks are pulling in opposite directions midday Friday, with Reddit (NYSE:RDDT) shares down 23% to $136.32, marking the stock’s worst intraday drop since its 2024 IPO. At the same time, Alphabet (NASDAQ:GOOGL) stock is up 6% to $352.45. The split is jarring because both names sit inside the same sector proxy. Meta Platforms ... Alphabet Jumps 6%, Reddit Craters 23% in Social Media Stock Divergence?

Innodata Inc (INOD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

As the Magnificent Seven stocks report earnings, the results have been broadly strong, but Microsoft, Amazon and Meta Platforms really stand out.

Microsoft's shares just surged 15% on earnings, yet the stock still lags where it started the year. Before you dismiss the move as too late, there are two fundamental signals buried in the results that the market has not fully priced in.

IonQ received regulatory approval to acquire SkyWater Technology, the largest exclusively U.S.-based semiconductor foundry. The deal gives IonQ direct control over a domestic chip manufacturing facility that is focused on U.S. production. This development affects IonQ's hardware supply chain and quantum computing build out inside the U.S. ecosystem. IonQ, traded as NYSE:IONQ, now has a material change in its operating setup as it moves from relying on external chip suppliers to owning a...

Stocks rose in midday trading Friday, erasing earlier losses as investors assessed earnings from maj

UNH's diversified platform, AI expansion and Optum momentum strengthen its long-term outlook, making it the stronger managed care pick over CNC.

KLA (KLAC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Qorvo (QRVO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

KLA (KLAC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ASML (ASML) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

MKS (MKSI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

MKS (MKSI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

(Bloomberg) -- Apnimed Inc., a late-stage drug developer focused on sleep apnea rose 6.3% on Friday after raising $192 million in an upsized US initial public offering.Most Read from BloombergSingapore's Gated Island for the Rich Is Marred by Decayed HomesAnthropic AI Models Hacked Three Organizations During TestsMicrosoft’s $450 Billion Jump Is Biggest in Stock Market HistoryChip Stocks Post Biggest Advance Since April 2025: Markets WrapUS Strikes Iran Again as Conflict Spreads Across Middle Ea

Oracle has cratered nearly 50% while its cloud rivals held steady, yet three Wall Street desks are calling for a price that would more than triple your money from here, and a blockbuster new partnership just gave that thesis a serious jolt.